Johnson & Johnson

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.

CEO

Joaquin Duato

CEOJoaquin Duato

Employees

131,900

Employees131,900

Headquarters

New Brunswick, New Jersey

HeadquartersNew Brunswick, New Jersey

Founded

1887

Founded1887

Employees

131,900

Employees131,900

JNJ Key Statistics

Market cap

352.14B

Market cap352.14B

Price-Earnings ratio

18.72

Price-Earnings ratio18.72

Dividend yield

3.26%

Dividend yield3.26%

Average volume

9.41M

Average volume9.41M

High today

$147.17

High today$147.17

Low today

$145.78

Low today$145.78

Open price

$146.61

Open price$146.61

Volume

6.18M

Volume6.18M

52 Week high

$175.97

52 Week high$175.97

52 Week low

$143.13

52 Week low$143.13

JNJ News

Yahoo Finance 9h

Johnson & Johnson Stock: Buy, Sell, or Hold? - Yahoo Finance

Johnson & Johnson (NYSE: JNJ) is an iconic name in healthcare, with a history that goes back to the 1800s. But in recent years it has faced some considerable ch...

Yahoo Finance 2d

Cidara buys back rights to flu therapy from J&J for $85m - Yahoo Finance

Cidara Therapeutics has entered into a definitive agreement with Johnson & Johnson (J&) to buy back the rights to its influenza therapy, CD388. Cidara will pay...

Simply Wall St 2d

Johnson & Johnson's Dividend Will Be Increased To $1.24

Johnson & Johnson (NYSE:JNJ) has announced that it will be increasing its dividend from last year's comparable payment on the 4th of June to $1.24. This will ta...

Analyst ratings

57%

of 23 ratings

Buy

43.5%

Hold

56.5%

Sell

More JNJ News

TipRanks 3d

LLY vs. JNJ: Which Big Pharma Stock Is Better? - TipRanks.com - TipRanks

In this piece, I evaluated two big pharma stocks, Eli Lilly (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ), using TipRanks’ Comparison Tool below. A closer look su...

TipRanks 3d

Cidara Therapeutics reacquires rights to CD388 from Johnson & Johnson for $85M

Cidara Therapeutics (CDTX) announced that it has entered into a definitive agreement with Johnson & Johnson (JNJ) to reacquire the exclusive global development...

Yahoo Finance 3d

The Zacks Analyst Blog Highlights KB Home, Interactive Brokers Group, Qualcomm and Johnson & Johnson - Yahoo Finance

For Immediate Release Chicago, IL – April 24, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research a...

Yahoo Finance 5d

Johnson & Johnson Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might aff...